Cannell Capital - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 64 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.

Quarter-by-quarter ownership
Cannell Capital ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2023$30,976
-3.2%
16,8350.0%0.01%0.0%
Q4 2022$31,987
-11.1%
16,8350.0%0.01%
-25.0%
Q3 2022$36,000
+227.3%
16,835
+320.8%
0.01%
+300.0%
Q2 2022$11,0004,0010.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,346,829$39,278,16563.85%
TFG Asset Management GP Ltd 10,000,000$18,400,0002.46%
Odey Asset Management Group Ltd 2,499,400$4,598,8961.21%
Deep Track Capital, LP 15,000,000$27,600,0001.13%
Nantahala Capital Management 7,691,813$14,152,9361.08%
DAFNA Capital Management LLC 1,176,150$2,164,1160.65%
Frazier Life Sciences Management, L.P. 3,746,857$6,894,2170.50%
ARMISTICE CAPITAL, LLC 9,672,000$17,796,4800.26%
Blackstone Inc. 20,485,611$37,693,5240.15%
HARBOR CAPITAL ADVISORS, INC. 222,149$408,7540.12%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders